Standard Biotools (LAB) Return on Capital Employed (2011 - 2026)
Standard Biotools (LAB) reported Return on Capital Employed of 17.07% for Q1 2026, down 1679.0% year-over-year from 1.08% in Q1 2025, and up 31.06% on a QoQ basis from 24.75% in Q4 2025.
Standard Biotools (LAB) has 16 years of Return on Capital Employed data on file, last reported at 17.07% in Q1 2026.
- Quarterly Return on Capital Employed fell 1679.0% year-over-year to 17.07% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 17.07% (down 1679.0% YoY) and the FY2025 annual result came in at 22.89%, down 1816.0% from the prior year.
- Return on Capital Employed improved to 17.07% in Q1 2026 per LAB's latest filing, from 24.75% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 0.65% in Q2 2025 and bottomed at 36.97% in Q1 2022.
- The 5-year median for Return on Capital Employed is 17.07% (2026), against an average of 18.23%.
- The widest annual swing landed in 2023, when Return on Capital Employed jumped 2533 bps; it then tumbled 1878 bps in 2025.
- Tracing LAB's Return on Capital Employed over 5 years: stood at 32.35% in 2022, then surged by 78 bps to 7.02% in 2023, then rose by 15 bps to 5.98% in 2024, then plunged by 314 bps to 24.75% in 2025, then soared by 31 bps to 17.07% in 2026.
- Per Business Quant, the three latest LAB Return on Capital Employed figures stand at 17.07% (Q1 2026), 24.75% (Q4 2025), and 0.72% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn | -17.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.07% |
| Dec 31, 2025 | -24.75% |
| Sep 30, 2025 | -0.72% |
| Jun 30, 2025 | 0.65% |
| Mar 31, 2025 | -0.28% |
| Dec 31, 2024 | -5.98% |
| Sep 30, 2024 | -13.49% |
| Jun 30, 2024 | -11.62% |
| Mar 31, 2024 | -13.80% |
| Dec 31, 2023 | -7.02% |
| Sep 30, 2023 | -25.81% |
| Jun 30, 2023 | -26.56% |
| Mar 31, 2023 | -31.23% |
| Dec 31, 2022 | -32.35% |
| Sep 30, 2022 | -30.04% |
| Jun 30, 2022 | -32.81% |
| Mar 31, 2022 | -36.97% |
| Sep 30, 2021 | -30.66% |
| Jun 30, 2021 | -24.12% |
| Mar 31, 2021 | -21.19% |
| Dec 31, 2020 | -18.93% |
| Sep 30, 2020 | -16.67% |
| Jun 30, 2020 | -20.84% |
| Mar 31, 2020 | -21.71% |
| Dec 31, 2019 | -22.13% |
| Sep 30, 2019 | -22.11% |
| Jun 30, 2019 | -20.61% |
| Mar 31, 2019 | -18.89% |
| Dec 31, 2018 | -20.04% |
| Sep 30, 2018 | -21.11% |
| Jun 30, 2018 | -21.85% |
| Mar 31, 2018 | -21.84% |
| Dec 31, 2017 | -22.78% |
| Sep 30, 2017 | -26.56% |
| Jun 30, 2017 | -27.94% |
| Mar 31, 2017 | -26.80% |
| Dec 31, 2016 | -25.78% |
| Sep 30, 2016 | -22.81% |
| Jun 30, 2016 | -18.52% |
| Mar 31, 2016 | -16.59% |
| Dec 31, 2015 | -14.57% |
| Sep 30, 2015 | -12.99% |
| Jun 30, 2015 | -14.19% |
| Mar 31, 2015 | -13.09% |
| Dec 31, 2014 | -13.66% |
| Sep 30, 2014 | -12.06% |
| Jun 30, 2014 | -9.79% |
| Mar 31, 2014 | -12.31% |
| Dec 31, 2013 | -19.11% |
| Sep 30, 2013 | -17.85% |
| Jun 30, 2013 | -16.30% |
| Mar 31, 2013 | -16.53% |
| Dec 31, 2012 | -17.41% |
| Sep 30, 2012 | -22.54% |
| Jun 30, 2012 | -33.38% |
| Mar 31, 2012 | -34.88% |
| Dec 31, 2011 | -30.54% |
| Sep 30, 2011 | -27.30% |